等待开盘 08-01 09:30:00 美东时间
0.000
0.00%
据港交所7月30日披露,丹诺医药(苏州)股份有限公司向港交所主板递交上市申请,中信证券和农银国际为联席保荐人。
07-31 06:46
Tonix Pharmaceuticals announced the publication of full results from its Phase 3 RESILIENT trial, showing that TNX-102 SL significantly reduced fibromyalgia pain compared to placebo, confirming prior RELIEF trial results. The drug, a non-opioid analgesic, was generally well-tolerated with mild side effects. The FDA has set an August 15, 2025 PDUFA date for review, and if approved, TNX-102 SL would be the first new fibromyalgia treatment in over 1...
07-09 20:01
ATHENS, Greece, June 18, 2025 (GLOBE NEWSWIRE) -- TEN Ltd. (NYSE: TEN) ("TEN" o...
06-19 04:05
Jefferies analyst Omar Nokta maintains Tsakos Energy Navigation (NYSE:TNP) with a Buy and maintains $30 price target.
2024-03-28 03:30
Understanding Value Stocks A value stock is traditionally defined in terms of h...
2024-02-01 22:39
Green initiative newbuilding program on trackRed Sea tensions further boosts tanker ratesATHENS, Greece, Jan. 22, 2024 (GLOBE NEWSWIRE) -- TEN, Ltd (TEN) (NYSE:TNP) (the "Company") announces the sale of the 2005-built
2024-01-22 22:22
Tsakos Energy Navigation Ltd (NYSE: TNP) reported a Q3 FY23 Voyage revenue of $186.659 million, beating the consensus of $166.139 million.
2023-11-22 02:12
Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is likely to report quarterly earnings at $1.60 per share on revenue of $174.10 million.
2023-09-07 18:25